Industryweek 6671 Allergan Board Rejects Valeant Takeover Bid

Allergan Board Rejects Valeant Takeover Bid

May 12, 2014
U.S. Botox maker Allergan rejects a takeover bid from Valeant Pharmaceuticals, saying it grossly undervalued the company and questioning the Canadian firm's long-term growth plan.

NEW YORK – U.S. Botox maker Allergan (IW 500/179) rejected Monday a takeover bid from Valeant Pharmaceuticals (IW 1000/959), saying it grossly undervalued the company and questioning the Canadian firm's long-term growth plan.

Allergan's board of directors unanimously turned down the unsolicited offer from Valeant, worth nearly $46 billion, highlighting its significant risks, the company said.

"After careful review and consideration, our board of directors has unanimously determined that Valeant's unsolicited proposal substantially undervalues Allergan," Allergan CEO David Pyott said in a statement.

Valeant Pharmaceuticals International, backed by activist shareholder William Ackman's Pershing Square investment group, proposed a stock-and-cash deal buyout on April 22 valuing Allergan at $45.6 billion.

On the eve of the takeover bid, Valeant and Ackman disclosed that they established a joint venture to make the offer, with Ackman said that Pershing Square had acquired 28.9 million shares of Allergan, or 9.7% of the company.

Valeant, headquartered in Laval, Quebec, says the acquisition will enable huge cost savings and create a leader in opthalmology, dermatology, aesthetics and other growing health fields.

Under the terms of the proposal, Valeant would buy each Allergan share for $48.30 in cash plus 0.83 shares of Valeant, saying the bid represented a "substantial" premium to Allergan's valuation.

Allergan shares fell 1.0% to $159.65 and Valeant shares dropped 0.9% to $129.98% in late-afternoon trade in New York.

Copyright Agence France-Presse, 2014

Popular Sponsored Recommendations

Navigating Disruption: A Leader’s Guide to Strategy Under Uncertainty

Nov. 1, 2023
AI, sustainability, digital--industrials are facing disruptive forces that are redefining what it takes to win. What got your company where it is today won’t get you where you...

Seizing the digital opportunity – An industrial software action plan

Aug. 9, 2023
Industrial enterprises are under pressure to adopt a digital-driven approach for their operations and for interacting with markets, customers, and the world around us. As modern...

Disruptive EV Technologies Are Driving New Supplier Realities

Sept. 20, 2023
Vehicle electrification is upending the automotive landscape, forcing suppliers to make critical strategic and operational decisions. Understand what that means for you in our...

Risk-Based Asset Management (RBAM): Accounting for Risk in Your Asset Management Strategy

Sept. 14, 2023
What if you could get more out of assets, reduce the risk of critical failures AND keep all your stakeholders happy? It’s called risk-based asset management, or RBAM, and it’ll...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!